Platinum-Based Cancer Drugs Market Size, Share, Trends, Industry Analysis Report: By Type, Application, Distribution Channel, and Region

Description

List of Tables

The global platinum-based cancer drugs market size is expected to reach USD 2,733.24 million by 2034, according to a new study by Polaris Market Research. The report "Platinum-Based Cancer Drugs Market Size, Share, Trends, Industry Analysis Report: By Type (Cisplatin, Oxaliplatin, Carboplatin, and Others), Application, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle, East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing prevalence of various cancers, such as ovarian, lung, and colorectal cancer, that require effective chemotherapy treatments drives the platinum-based cancer drugs market growth. Key market growth drivers include the continued effectiveness of platinum-based drugs such as cisplatin, carboplatin, and oxaliplatin in treating solid tumors and advancements in combination therapies and personalized medicine that enhance treatment outcomes. Opportunities exist in emerging markets where access to cancer treatments is expanding, as well as in the development of new drug formulations aimed at reducing side effects and improving drug delivery.

A few platinum-based cancer drugs market trends such as the rise of combination therapies, the focus on reducing toxicity, and the growing availability of generic platinum drugs would contribute to the market's overall expansion during the forecast period. As research progresses and new applications for platinum-based drugs are explored, the market is poised for continued growth, addressing both the demand for better cancer treatments and the need for affordable therapies worldwide.

Platinum-Based Cancer Drugs Market Report Highlights

Based on type, the Cisplatin segment dominates the platinum-based cancer drugs market share due to its long-standing use and effectiveness in treating various cancers, including ovarian and testicular cancer. However, the oxaliplatin segment is the fastest-growing, driven by its increasing application in colorectal cancer treatments and combination therapies.

The ovarian cancer segment, by application, holds the largest market share, owing to the high efficacy of platinum-based drugs such as cisplatin and carboplatin in treating this cancer. Lung cancer is the fastest-growing segment, primarily due to the rising incidence of non-small cell lung cancer and the use of platinum-based therapies in combination with other drugs.

By distribution channel, the hospital-based pharmacies segment dominates the market as they are the primary providers of chemotherapy drugs, including platinum-based treatments, for inpatient care and cancer treatments. Online pharmacies are experiencing the highest growth, driven by the increasing trend of remote healthcare and patient convenience for prescription refills and outpatient treatments.

North America holds the largest share of the global market, largely due to advanced healthcare infrastructure and high cancer incidence rates in the region. Asia Pacific is the highest-growing region, fueled by the increasing cancer burden, improving healthcare access, and rising adoption of platinum-based therapies in countries such as China and India.

Polaris Market Research has segmented the platinum-based cancer drugs market report on the basis of type, application, distribution channel, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

Cisplatin
Oxaliplatin
Carboplatin
Others

By Application Outlook (Revenue - USD Million, 2020-2034)

Colorectal Cancer
Ovarian Cancer
Lung Cancer
Others

By Distribution Channel Outlook (Revenue - USD Million, 2020-2034)

Hospital-Based Pharmacies
Retail Pharmacies
Online Pharmacies

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM1635

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Platinum-Based Cancer Drugs Market Insights

4.1. Platinum-Based Cancer Drugs Market - Market Snapshot
4.2. Platinum-Based Cancer Drugs Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Adoption of Platinum-Based Chemotherapy in Cancer Treatment
  - 4.2.1.2. Ongoing Research in Combination Therapies
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Platinum-Based Cancer Drugs Market Distribution Channel Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Platinum-Based Cancer Drugs Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
5.3. Cisplatin
- 5.3.1. Global Platinum-Based Cancer Drugs Market, by Cisplatin, by Region, 2020-2034 (USD Million)
5.4. Oxaliplatin
- 5.4.1. Global Platinum-Based Cancer Drugs Market, by Oxaliplatin, by Region, 2020-2034 (USD Million)
5.5. Carboplatin
- 5.5.1. Global Platinum-Based Cancer Drugs Market, by Carboplatin, by Region, 2020-2034 (USD Million)
5.6. Others
- 5.6.1. Global Platinum-Based Cancer Drugs Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Platinum-Based Cancer Drugs Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
6.3. Colorectal Cancer
- 6.3.1. Global Platinum-Based Cancer Drugs Market, by Colorectal Cancer, by Region, 2020-2034 (USD Million)
6.4. Ovarian Cancer
- 6.4.1. Global Platinum-Based Cancer Drugs Market, by Ovarian Cancer, by Region, 2020-2034 (USD Million)
6.5. Lung Cancer
- 6.5.1. Global Platinum-Based Cancer Drugs Market, by Lung Cancer, by Region, 2020-2034 (USD Million)
6.6. Others
- 6.6.1. Global Platinum-Based Cancer Drugs Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Platinum-Based Cancer Drugs Market, by Distribution Channel

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
7.3. Hospital-Based Pharmacies
- 7.3.1. Global Platinum-Based Cancer Drugs Market, by Hospital-Based Pharmacies, by Region, 2020-2034 (USD Million)
7.4. Retail Pharmacies
- 7.4.1. Global Platinum-Based Cancer Drugs Market, by Retail Pharmacies, by Region, 2020-2034 (USD Million)
7.5. Online Pharmacies
- 7.5.1. Global Platinum-Based Cancer Drugs Market, by Online Pharmacies, by Region, 2020-2034 (USD Million)

8. Global Platinum-Based Cancer Drugs Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Platinum-Based Cancer Drugs Market Assessment, By Geography, 2020-2034 (USD Million)
8.3. Platinum-Based Cancer Drugs Market - North America
- 8.3.1. North America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
- 8.3.2. North America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
- 8.3.3. North America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.3.4. Platinum-Based Cancer Drugs Market - U.S.
  - 8.3.4.1. U.S.: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.3.4.2. U.S.: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.3.4.3. U.S.: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.3.5. Platinum-Based Cancer Drugs Market - Canada
  - 8.3.5.1. Canada: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.3.5.2. Canada: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.3.5.3. Canada: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
8.4. Platinum-Based Cancer Drugs Market - Europe
- 8.4.1. Europe: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
- 8.4.2. Europe: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
- 8.4.3. Europe: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.4. Platinum-Based Cancer Drugs Market - UK
  - 8.4.4.1. UK: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.4.4.2. UK: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.4.4.3. UK: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.5. Platinum-Based Cancer Drugs Market - France
  - 8.4.5.1. France: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.4.5.2. France: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.4.5.3. France: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.6. Platinum-Based Cancer Drugs Market - Germany
  - 8.4.6.1. Germany: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.4.6.2. Germany: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.4.6.3. Germany: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.7. Platinum-Based Cancer Drugs Market - Italy
  - 8.4.7.1. Italy: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.4.7.2. Italy: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.4.7.3. Italy: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.8. Platinum-Based Cancer Drugs Market - Spain
  - 8.4.8.1. Spain: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.4.8.2. Spain: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.4.8.3. Spain: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.9. Platinum-Based Cancer Drugs Market - Netherlands
  - 8.4.9.1. Netherlands: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.4.9.2. Netherlands: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.4.9.3. Netherlands: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.10. Platinum-Based Cancer Drugs Market - Russia
  - 8.4.10.1. Russia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.4.10.2. Russia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.4.10.3. Russia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.4.11. Platinum-Based Cancer Drugs Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.4.11.2. Rest of Europe: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.4.11.3. Rest of Europe: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
8.5. Platinum-Based Cancer Drugs Market - Asia Pacific
- 8.5.1. Asia Pacific: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.4. Platinum-Based Cancer Drugs Market - China
  - 8.5.4.1. China: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.5.4.2. China: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.5.4.3. China: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.5. Platinum-Based Cancer Drugs Market - India
  - 8.5.5.1. India: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.5.5.2. India: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.5.5.3. India: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.6. Platinum-Based Cancer Drugs Market - Malaysia
  - 8.5.6.1. Malaysia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.5.6.2. Malaysia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.5.6.3. Malaysia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.7. Platinum-Based Cancer Drugs Market - Japan
  - 8.5.7.1. Japan: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.5.7.2. Japan: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.5.7.3. Japan: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.8. Platinum-Based Cancer Drugs Market - Indonesia
  - 8.5.8.1. Indonesia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.5.8.2. Indonesia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.5.8.3. Indonesia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.9. Platinum-Based Cancer Drugs Market - South Korea
  - 8.5.9.1. South Korea: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.5.9.2. South Korea: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.5.9.3. South Korea: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.10. Platinum-Based Cancer Drugs Market - Australia
  - 8.5.10.1. Australia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.5.10.2. Australia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.5.10.3. Australia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.5.11. Platinum-Based Cancer Drugs Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.5.11.2. Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.5.11.3. Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
8.6. Platinum-Based Cancer Drugs Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.4. Platinum-Based Cancer Drugs Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.6.4.2. Saudi Arabia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.6.4.3. Saudi Arabia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.5. Platinum-Based Cancer Drugs Market - UAE
  - 8.6.5.1. UAE: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.6.5.2. UAE: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.6.5.3. UAE: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.6. Platinum-Based Cancer Drugs Market - Israel
  - 8.6.6.1. Israel: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.6.6.2. Israel: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.6.6.3. Israel: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.7. Platinum-Based Cancer Drugs Market - South Africa
  - 8.6.7.1. South Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.6.7.2. South Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.6.7.3. South Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.6.8. Platinum-Based Cancer Drugs Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.6.8.2. Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.6.8.3. Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
8.7. Platinum-Based Cancer Drugs Market - Latin America
- 8.7.1. Latin America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
- 8.7.2. Latin America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
- 8.7.3. Latin America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.4. Platinum-Based Cancer Drugs Market - Mexico
  - 8.7.4.1. Mexico: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.7.4.2. Mexico: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.7.4.3. Mexico: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.5. Platinum-Based Cancer Drugs Market - Brazil
  - 8.7.5.1. Brazil: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.7.5.2. Brazil: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.7.5.3. Brazil: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.6. Platinum-Based Cancer Drugs Market - Argentina
  - 8.7.6.1. Argentina: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.7.6.2. Argentina: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.7.6.3. Argentina: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.7.7. Platinum-Based Cancer Drugs Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  - 8.7.7.2. Rest of Latin America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  - 8.7.7.3. Rest of Latin America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Bristol-Myers Squibb
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Eli Lilly and Company
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Sanofi
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Pfizer
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Novartis
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Johnson & Johnson
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Teva Pharmaceutical Industries
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Hikma Pharmaceuticals
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Mylan
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. AstraZeneca
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. GlaxoSmithKline
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Bayer
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. Merck & Co.
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. Amgen
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
10.15. Sun Pharmaceutical Industries
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development